Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044968621> ?p ?o ?g. }
- W3044968621 endingPage "105979" @default.
- W3044968621 startingPage "105979" @default.
- W3044968621 abstract "Per- and polyfluoroalkyl substances (PFAS) are widely used bio-accumulative chemicals in many industrial and household products. Experimental studies reported that exposure to PFAS results in immunotoxicity. We have previously reported that prenatal exposure to PFAS decreased the risk of allergies, while it increased the risk of infectious diseases at ages 2 and 4 years. However, it remains unclear whether the adverse effects of PFAS on allergies and infectious diseases continue until a reliable age of diagnosing allergies. This study aimed at investigating the effects of prenatal exposure to PFAS on the prevalence of allergies and infectious diseases in children up to age 7, from the Hokkaido Study. Among mother-child pairs enrolled in the Hokkaido study and followed up until the age of 7 years, 2689 participants with maternal PFAS, 1st trimester of pregnancy and 7-year-old questionnaire survey data were included in this study. Eleven PFAS in the 3rd-trimester plasma were measured using ultra-performance liquid chromatography coupled to triple quadrupole tandem mass spectrometry. Wheeze, rhino-conjunctivitis, and eczema were defined using the International Study of Asthma and Allergies on Childhood (ISAAC) questionnaire. History childhood infectious diseases diagnosed by a doctor was assessed by a mother-reported questionnaire at child’s age 7. The relative risk of childhood allergies was calculated by generalized estimating equation models. The odds ratio of an episode of infectious diseases was calculated by logistic regression analysis, adjusted for potential confounders. The prevalence of various allergies and infectious diseases was: wheeze, 11.9%; rhino-conjunctivitis, 11.3%; eczema, 21.0%; chickenpox, 61.5%; otitis media, 55.7%; pneumonia, 30.6%; and respiratory syncytial virus infection, 16.8%. Prenatal exposure to perfluorooctanoic acid, perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid (PFUnDA) was inversely associated with rhino-conjunctivitis, while that for perfluorooctanoate (PFOA), perfluorooctane sulfonate, PFUnDA, perfluorododecanoic acid (PFDoDA), and perfluorotridecanoic acid was inversely associated with eczema. For infectious diseases, PFDA and PFDoDA were associated with increased risk of pneumonia and PFOA was associated with increased risk of RSV infection among children not having any siblings (only-one-child). Our results corroborate the hypothesis on immunosuppressive and immunomodulating effects of PFAS on allergies and infectious diseases in children. These effects observed previously at 2 and 4 years continued until the age of 7 years. However, additional studies assessing inflammatory biomarkers along with ISAAC questionnaires, doctor-diagnosed allergies, and longer follow-ups are necessary to better assess the effects of exposure to chemicals on human immune outcomes." @default.
- W3044968621 created "2020-07-29" @default.
- W3044968621 creator A5000595716 @default.
- W3044968621 creator A5004973831 @default.
- W3044968621 creator A5009419480 @default.
- W3044968621 creator A5041781773 @default.
- W3044968621 creator A5058104472 @default.
- W3044968621 creator A5065534987 @default.
- W3044968621 creator A5087081534 @default.
- W3044968621 date "2020-10-01" @default.
- W3044968621 modified "2023-10-09" @default.
- W3044968621 title "Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health" @default.
- W3044968621 cites W1966078713 @default.
- W3044968621 cites W1975902105 @default.
- W3044968621 cites W1986194759 @default.
- W3044968621 cites W2000700166 @default.
- W3044968621 cites W2011706851 @default.
- W3044968621 cites W2028930921 @default.
- W3044968621 cites W2055564344 @default.
- W3044968621 cites W2055623806 @default.
- W3044968621 cites W2056547176 @default.
- W3044968621 cites W2062930348 @default.
- W3044968621 cites W2064994678 @default.
- W3044968621 cites W2074930631 @default.
- W3044968621 cites W2084964986 @default.
- W3044968621 cites W2094312014 @default.
- W3044968621 cites W2114468696 @default.
- W3044968621 cites W2120793327 @default.
- W3044968621 cites W2134261811 @default.
- W3044968621 cites W2142010704 @default.
- W3044968621 cites W2144144303 @default.
- W3044968621 cites W2274939513 @default.
- W3044968621 cites W2317877517 @default.
- W3044968621 cites W2321830102 @default.
- W3044968621 cites W2331131609 @default.
- W3044968621 cites W2394821873 @default.
- W3044968621 cites W2515907736 @default.
- W3044968621 cites W2528899831 @default.
- W3044968621 cites W2574940205 @default.
- W3044968621 cites W2605027876 @default.
- W3044968621 cites W2616242281 @default.
- W3044968621 cites W2767278905 @default.
- W3044968621 cites W2787010356 @default.
- W3044968621 cites W2790439914 @default.
- W3044968621 cites W2802560127 @default.
- W3044968621 cites W2807328496 @default.
- W3044968621 cites W2900175200 @default.
- W3044968621 cites W2901343691 @default.
- W3044968621 cites W2914193584 @default.
- W3044968621 cites W2914438210 @default.
- W3044968621 cites W2952305169 @default.
- W3044968621 cites W2955878424 @default.
- W3044968621 cites W2974093525 @default.
- W3044968621 cites W2988902609 @default.
- W3044968621 cites W2989497657 @default.
- W3044968621 cites W2994186404 @default.
- W3044968621 doi "https://doi.org/10.1016/j.envint.2020.105979" @default.
- W3044968621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32717646" @default.
- W3044968621 hasPublicationYear "2020" @default.
- W3044968621 type Work @default.
- W3044968621 sameAs 3044968621 @default.
- W3044968621 citedByCount "33" @default.
- W3044968621 countsByYear W30449686212021 @default.
- W3044968621 countsByYear W30449686212022 @default.
- W3044968621 countsByYear W30449686212023 @default.
- W3044968621 crossrefType "journal-article" @default.
- W3044968621 hasAuthorship W3044968621A5000595716 @default.
- W3044968621 hasAuthorship W3044968621A5004973831 @default.
- W3044968621 hasAuthorship W3044968621A5009419480 @default.
- W3044968621 hasAuthorship W3044968621A5041781773 @default.
- W3044968621 hasAuthorship W3044968621A5058104472 @default.
- W3044968621 hasAuthorship W3044968621A5065534987 @default.
- W3044968621 hasAuthorship W3044968621A5087081534 @default.
- W3044968621 hasBestOaLocation W30449686211 @default.
- W3044968621 hasConcept C126322002 @default.
- W3044968621 hasConcept C151956035 @default.
- W3044968621 hasConcept C156957248 @default.
- W3044968621 hasConcept C187212893 @default.
- W3044968621 hasConcept C203014093 @default.
- W3044968621 hasConcept C207480886 @default.
- W3044968621 hasConcept C2776042228 @default.
- W3044968621 hasConcept C2778338976 @default.
- W3044968621 hasConcept C2779234561 @default.
- W3044968621 hasConcept C54355233 @default.
- W3044968621 hasConcept C71924100 @default.
- W3044968621 hasConcept C77350462 @default.
- W3044968621 hasConcept C86803240 @default.
- W3044968621 hasConcept C99454951 @default.
- W3044968621 hasConceptScore W3044968621C126322002 @default.
- W3044968621 hasConceptScore W3044968621C151956035 @default.
- W3044968621 hasConceptScore W3044968621C156957248 @default.
- W3044968621 hasConceptScore W3044968621C187212893 @default.
- W3044968621 hasConceptScore W3044968621C203014093 @default.
- W3044968621 hasConceptScore W3044968621C207480886 @default.
- W3044968621 hasConceptScore W3044968621C2776042228 @default.
- W3044968621 hasConceptScore W3044968621C2778338976 @default.
- W3044968621 hasConceptScore W3044968621C2779234561 @default.
- W3044968621 hasConceptScore W3044968621C54355233 @default.